SARS-CoV-2-IN-64
SARS-CoV-2-IN-64 (compound 9), a chenodeoxycholic acid derivative, is a potent inhibitor of spike glycoprotein of SARS-CoV-2[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-64.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(C=C1)C(O[C@H]2C[C@]([H])([C@@]3(CC2)C)C[C@H]([C@@]4([C@@]3(CC[C@]5([C@]4(CC[C@@H]5[C@H](C)CCC(OC(C)C)=O)[H])C)[H])[H])OC(C6=CC=C(C=C6)Cl)=O)=O
Molecular Formula
C41H52Cl2O6
Molecular Weight
711.75
References & Citations
[1]Gisele Rocha Aguiar, et al. Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. J Biomol Struct Dyn. 2023 Oct-Nov;41 (17) :8334-8348.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog